Omada Health Enhances GLP-1 Care Track to Support Customers Managing Medications and Integrates MSK Support The updated solution facilitates partner GLP-1 authorization workflows and supports members with individualized exercise plans SAN FRANCISCO -- February 13, 2024 - Omada Health, a leading virtual-first healthcare provider, announced an expansion of its GLP-1 companion solution, adding customized partner support for medication eligibility and expanded exercise programming that leverages its deep musculoskeletal (MSK) expertise
The information presented on this website is not intended to take the place of your personal physician's advice and is not intended to diagnose, treat, cure, or prevent any disease
Originally developed to treat type 2 diabetes, GLP-1 medications were quickly recognized for their extraordinary weight loss benefits
A dangerous drug interaction could occur
Changes in muscle metabolism are frequently intertwined with mechanisms of oxidative stress, mitochondrial function, and inflammation
Victoria, speaking: There's nothing that replaces those